News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2011

15 December, 2011 PledPharma’s clinical myocardial infarction study restarted after approval from the Medical Products Agency News English IR Optional
5 December, 2011 PledPharma’s PledOx® protects against white blood cell drop caused by the anticancer drug oxaliplatin News English IR Optional
27 October, 2011 Interim report January - September 2011 News English Report Interim Q3 IR Optional
20 September, 2011 PledPharma strengthens its organization News English IR Optional

Calendar and upcoming reports

April 15, 2024
Annual Report 2023

May 3, 2024
Interim Report Q1 2024 (7:00am CEST)

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com

Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept all”, you consent to the use of ALL the cookies. However, you may visit "Settings" to provide a controlled consent. Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all